FDMT vs H · rev $37.0K vs rev $6.65B
4D Molecular Therapeutics Inc (FDMT) versus Hyatt Hotels Corporation (H) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Hyatt Hotels Corporation (H) is a lodging company listed on US.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported H revenue for 2024-12-31 was $6.65B. Net income was $1.30B. Revenue was down 0.3% from 2023-12-31 to 2024-12-31. H currently screens at market cap $17.08B.
FDMT currently screens at market cap $518.1M. H currently screens at market cap $17.08B.
Not investment advice. Open the FDMT and H stock pages for the full models.
Not investment advice.